Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-Transplant Cyclophosphamide for GVHD Prophylaxis in MUD/MMUD HSCT
NCT02065154Phase 2Completed
- Sponsor
- University of Alabama at Birmingham
- Start
- Aug 2013
- Primary completion
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cyclophosphamide in graft-versus-host disease (GVHD), sponsored by University of Alabama at Birmingham. Started Aug 2013; status: completed.
02
Drugs
cyclophosphamide
03
Conditions
graft-versus-host disease (GVHD)
Beyond the preview
Go deeper on NCT02065154.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02065154.